Biogen Idec Inc. (BIIB) Financials Nov 18, 2014, 6
Post# of 250602
Posted On: 11/18/2014 9:47:20 PM
Biogen Idec Inc. (BIIB) Financials Nov 18, 2014, 6:06 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Biogen Idec Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 4.43B 4.67B 5.09B 5.48B 6.95B
Cost of Goods Sold (COGS) incl. D&A 671.92M 609.19M 675.35M 747.7M 1.2B
COGS excluding D&A 243.95M 255.09M 316.41M 382.05M 668.93M
Depreciation & Amortization Expense 427.96M 354.1M 358.93M 365.65M 531.74M
Depreciation 138.15M 145.17M 150.37M 163.44M 188.79M
Amortization of Intangibles 289.81M 208.93M 208.57M 202.2M 342.95M
Gross Income 3.76B 4.06B 4.41B 4.73B 5.74B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 2.19B 2.28B 2.28B 2.61B 3.24B
Research & Development 1.28B 1.25B 1.22B 1.33B 1.44B
Other SG&A 911.03M 1.03B 1.06B 1.28B 1.8B
Other Operating Expense 215.9M 258.07M 317.77M 317.9M 0
Unusual Expense 11.7M 337.53M 53.49M 34.53M (2.95M)
EBIT after Unusual Expense (11.7M) (337.53M) (53.49M) (34.53M) 2.95M
Non Operating Income/Expense (13.45M) 57.92M (38.18M) 93.25M (1.93M)
Non-Operating Interest Income 48.5M 22.3M 19.2M 29.5M 8.2M
Equity in Affiliates (Pretax) - - - - 0
Interest Expense 35.8M 36.1M 33M 36.5M 31.9M
Gross Interest Expense 64.3M 64.7M 65.6M 69.6M 39.7M
Interest Capitalized 28.5M 28.6M 32.6M 33.1M 7.8M
Pretax Income 1.33B 1.23B 1.71B 1.86B 2.48B
Income Tax 355.62M 331.33M 444.53M 470.55M 601.01M
Income Tax - Current Domestic 443.02M 377.3M 246.8M 543.45M 799.31M
Income Tax - Current Foreign 50M 35.4M 44.1M 44M 46.8M
Income Tax - Deferred Domestic (133.8M) (77.2M) 152.83M (146M) (236.5M)
Income Tax - Deferred Foreign (3.6M) (4.17M) 800,000 29.1M (8.6M)
Income Tax Credits - - - - 0
Equity in Affiliates - - - (4.52M) (17.22M)
Other After Tax Income (Expense) (1.7M) (2M) 0 0 0
Consolidated Net Income 975.36M 896.57M 1.27B 1.38B 1.86B
Minority Interest Expense 6.93M (106.7M) 32.26M 0 0
Net Income 968.43M 1B 1.23B 1.38B 1.86B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 968.43M 1B 1.23B 1.38B 1.86B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 968.43M 1B 1.23B 1.38B 1.86B
EPS (Basic) 3.37 3.98 5.09 5.80 7.86
Basic Shares Outstanding 287.36M 252.31M 242.4M 237.94M 236.92M
EPS (Diluted) 3.35 3.94 5.04 5.76 7.81
Diluted Shares Outstanding 289.48M 254.87M 245.03M 239.74M 238.31M
EBITDA 1.77B 1.88B 2.18B 2.17B 3.04B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Biogen Idec Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 4.43B 4.67B 5.09B 5.48B 6.95B
Cost of Goods Sold (COGS) incl. D&A 671.92M 609.19M 675.35M 747.7M 1.2B
COGS excluding D&A 243.95M 255.09M 316.41M 382.05M 668.93M
Depreciation & Amortization Expense 427.96M 354.1M 358.93M 365.65M 531.74M
Depreciation 138.15M 145.17M 150.37M 163.44M 188.79M
Amortization of Intangibles 289.81M 208.93M 208.57M 202.2M 342.95M
Gross Income 3.76B 4.06B 4.41B 4.73B 5.74B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 2.19B 2.28B 2.28B 2.61B 3.24B
Research & Development 1.28B 1.25B 1.22B 1.33B 1.44B
Other SG&A 911.03M 1.03B 1.06B 1.28B 1.8B
Other Operating Expense 215.9M 258.07M 317.77M 317.9M 0
Unusual Expense 11.7M 337.53M 53.49M 34.53M (2.95M)
EBIT after Unusual Expense (11.7M) (337.53M) (53.49M) (34.53M) 2.95M
Non Operating Income/Expense (13.45M) 57.92M (38.18M) 93.25M (1.93M)
Non-Operating Interest Income 48.5M 22.3M 19.2M 29.5M 8.2M
Equity in Affiliates (Pretax) - - - - 0
Interest Expense 35.8M 36.1M 33M 36.5M 31.9M
Gross Interest Expense 64.3M 64.7M 65.6M 69.6M 39.7M
Interest Capitalized 28.5M 28.6M 32.6M 33.1M 7.8M
Pretax Income 1.33B 1.23B 1.71B 1.86B 2.48B
Income Tax 355.62M 331.33M 444.53M 470.55M 601.01M
Income Tax - Current Domestic 443.02M 377.3M 246.8M 543.45M 799.31M
Income Tax - Current Foreign 50M 35.4M 44.1M 44M 46.8M
Income Tax - Deferred Domestic (133.8M) (77.2M) 152.83M (146M) (236.5M)
Income Tax - Deferred Foreign (3.6M) (4.17M) 800,000 29.1M (8.6M)
Income Tax Credits - - - - 0
Equity in Affiliates - - - (4.52M) (17.22M)
Other After Tax Income (Expense) (1.7M) (2M) 0 0 0
Consolidated Net Income 975.36M 896.57M 1.27B 1.38B 1.86B
Minority Interest Expense 6.93M (106.7M) 32.26M 0 0
Net Income 968.43M 1B 1.23B 1.38B 1.86B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 968.43M 1B 1.23B 1.38B 1.86B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 968.43M 1B 1.23B 1.38B 1.86B
EPS (Basic) 3.37 3.98 5.09 5.80 7.86
Basic Shares Outstanding 287.36M 252.31M 242.4M 237.94M 236.92M
EPS (Diluted) 3.35 3.94 5.04 5.76 7.81
Diluted Shares Outstanding 289.48M 254.87M 245.03M 239.74M 238.31M
EBITDA 1.77B 1.88B 2.18B 2.17B 3.04B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼